Use of defined TLR ligands as adjuvants within human vaccines
MS Duthie, HP Windish, CB Fox… - Immunological …, 2011 - Wiley Online Library
Our improved understanding of how innate immune responses can be initiated and how
they can shape adaptive B‐and T‐cell responses is having a significant impact on vaccine …
they can shape adaptive B‐and T‐cell responses is having a significant impact on vaccine …
Current challenges for cancer vaccine adjuvant development
WS Bowen, AK Svrivastava, L Batra… - Expert review of …, 2018 - Taylor & Francis
Introduction: Although much progress has been made in the last decade (s) toward
development of effective cancer vaccines, there are still important obstacles to therapeutic …
development of effective cancer vaccines, there are still important obstacles to therapeutic …
Irinotecan-and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
RA Ribeiro, CWS Wanderley, DVT Wong… - Cancer chemotherapy …, 2016 - Springer
Purpose Intestinal mucositis and diarrhea are common manifestations of anticancer
regimens that include irinotecan, 5-fluorouracil (5-FU), and other cytotoxic drugs. These side …
regimens that include irinotecan, 5-fluorouracil (5-FU), and other cytotoxic drugs. These side …
[HTML][HTML] Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis
Y Lin, S Ritchea, A Logar, S Slight, M Messmer… - Immunity, 2009 - cell.com
The importance of T helper type 1 (Th1) cell immunity in host resistance to the intracellular
bacterium Francisella tularensis is well established. However, the relative roles of interleukin …
bacterium Francisella tularensis is well established. However, the relative roles of interleukin …
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy
ELJM Smits, P Ponsaerts, ZN Berneman… - The …, 2008 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader should be able to:
Describe the subtypes of Toll-like receptor 7 and 8 agonists and their effect on the different …
Describe the subtypes of Toll-like receptor 7 and 8 agonists and their effect on the different …
TLR cross-talk confers specificity to innate immunity
Cross-talk within the innate immune pathways is highly complex and contains many
unknowns. Here, we discuss the different combinations of PAMPs, together with the …
unknowns. Here, we discuss the different combinations of PAMPs, together with the …
Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants
C Olive - Expert review of vaccines, 2012 - Taylor & Francis
The innate immune system plays an essential role in the host's first line of defense against
microbial invasion, and involves the recognition of distinct pathogen-associated molecular …
microbial invasion, and involves the recognition of distinct pathogen-associated molecular …
Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines
Q Zhu, C Egelston, A Vivekanandhan… - Proceedings of the …, 2008 - National Acad Sciences
Toll-like receptors (TLRs) may need to cooperate with each other to be effective in detecting
imminent infection and trigger immune responses. Understanding is still limited about the …
imminent infection and trigger immune responses. Understanding is still limited about the …
Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells
SM Mäkelä, M Strengell, TE Pietilä… - Journal of Leucocyte …, 2009 - academic.oup.com
TLRs are innate immune receptors that recognize pathogen-associated structures. Binding
of ligands to different TLRs can induce the production of proinflammatory cytokines in a …
of ligands to different TLRs can induce the production of proinflammatory cytokines in a …
[HTML][HTML] IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity
BM Carreno, M Becker-Hapak, A Huang… - The Journal of …, 2013 - Am Soc Clin Investig
Background. Systemic administration of IL-12p70 has demonstrated clinical activity in
cancer patients, but dose-limiting toxicities have hindered its incorporation in vaccine …
cancer patients, but dose-limiting toxicities have hindered its incorporation in vaccine …